tiprankstipranks
Trending News
More News >
Insecticides (India) Limited (IN:INSECTICID)
:INSECTICID
India Market
Advertisement

Insecticides (India) Limited (INSECTICID) AI Stock Analysis

Compare
1 Followers

Top Page

IN:INSECTICID

Insecticides (India) Limited

(INSECTICID)

Rating:72Outperform
Price Target:
₹1,005.00
▼(-1.95% Downside)
Insecticides (India) Limited shows strong financial performance with robust revenue and profit growth, contributing significantly to the overall score. Technical analysis indicates a bearish trend but potential for reversal, while valuation metrics suggest the stock is fairly valued. The absence of earnings call and corporate events data limits additional insights.

Insecticides (India) Limited (INSECTICID) vs. iShares MSCI India ETF (INDA)

Insecticides (India) Limited Business Overview & Revenue Model

Company DescriptionInsecticides (India) Limited (INSECTICID) is a prominent agrochemical company based in India, specializing in the manufacture and distribution of a wide range of crop protection products. The company's portfolio includes insecticides, herbicides, fungicides, and other agricultural chemicals designed to enhance crop yields and protect them from pests and diseases. With a strong focus on research and development, Insecticides (India) Limited aims to deliver effective and innovative solutions to farmers, ensuring sustainable agricultural practices across the country.
How the Company Makes MoneyInsecticides (India) Limited generates revenue primarily through the sale of its agrochemical products, which cater to the needs of farmers and agricultural businesses. The company's key revenue streams include the manufacturing and distribution of insecticides, herbicides, and fungicides. These products are sold through an extensive network of distributors and retailers across India. In addition to domestic sales, the company may also engage in export activities, contributing to its revenue. Strategic partnerships with research institutions and technology providers help in the development of new products and solutions, thereby enhancing the company's competitive edge in the market. Furthermore, Insecticides (India) Limited invests in marketing and promotional activities to increase brand awareness and expand its customer base, which also plays a crucial role in driving sales and revenue.

Insecticides (India) Limited Financial Statement Overview

Summary
Insecticides (India) Limited shows a positive financial trajectory with strong revenue and profit growth, a stable balance sheet, and healthy cash flow generation. Despite fluctuations in EBIT margins and rising liabilities, the financial health is robust.
Income Statement
82
Very Positive
Insecticides (India) Limited has shown consistent revenue growth with a substantial increase from 14,021 million in 2021 to 19,999 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management. The net profit margin has also strengthened, reflecting enhanced profitability. However, the EBIT margin has fluctuated, which suggests some operational challenges.
Balance Sheet
78
Positive
The company maintains a solid equity base with an increasing trend in stockholders' equity from 8,203 million in 2021 to 10,846 million in 2025. The debt-to-equity ratio is relatively low and manageable, indicating prudent leverage. The equity ratio shows a stable asset financing structure. Nonetheless, the consistent rise in total liabilities could pose future financial risks.
Cash Flow
75
Positive
Insecticides (India) Limited exhibits a strong free cash flow position with growth over the years, except for a dip in 2023. The operating cash flow to net income ratio indicates robust cash generation relative to reported profits. However, fluctuations in free cash flow highlight potential volatility in capital expenditure and financing activities.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue20.00B19.56B17.97B14.98B14.12B
Gross Profit6.41B4.80B3.99B3.79B3.35B
EBITDA2.29B1.72B1.21B1.73B1.48B
Net Income1.42B1.02B632.11M1.07B939.03M
Balance Sheet
Total Assets18.98B17.13B16.96B13.96B14.26B
Cash, Cash Equivalents and Short-Term Investments747.07M613.50M196.42M360.96M81.44M
Total Debt1.05B873.09M1.63B539.50M1.00B
Total Liabilities8.14B7.00B7.78B5.27B6.06B
Stockholders Equity10.85B10.14B9.18B8.70B8.20B
Cash Flow
Free Cash Flow561.68M1.35B-980.91M675.70M1.07B
Operating Cash Flow934.57M1.84B-106.33M1.35B1.55B
Investing Cash Flow-377.20M-429.91M-864.03M93.09M-1.13B
Financing Cash Flow-610.92M-980.58M796.80M-1.15B-1.04B

Insecticides (India) Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1025.00
Price Trends
50DMA
962.49
Positive
100DMA
829.41
Positive
200DMA
754.61
Positive
Market Momentum
MACD
15.36
Positive
RSI
55.10
Neutral
STOCH
28.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INSECTICID, the sentiment is Positive. The current price of 1025 is above the 20-day moving average (MA) of 1018.98, above the 50-day MA of 962.49, and above the 200-day MA of 754.61, indicating a bullish trend. The MACD of 15.36 indicates Positive momentum. The RSI at 55.10 is Neutral, neither overbought nor oversold. The STOCH value of 28.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:INSECTICID.

Insecticides (India) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹28.71B7.75
1.69%23.22%39.31%
72
Outperform
₹29.83B21.19
0.51%1.73%38.99%
63
Neutral
$21.01B14.53-6.78%3.13%3.36%-7.91%
63
Neutral
₹2.17B5.28
7.55%46.94%
62
Neutral
₹11.03B31.94
1.20%13.67%-49.85%
47
Neutral
₹28.94B
-11.30%-66.53%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:INSECTICID
Insecticides (India) Limited
905.05
17.26
1.94%
IN:ANDHRSUGAR
Andhra Sugars Limited
81.36
-25.55
-23.90%
IN:BAJAJHIND
Bajaj Hindusthan Sugar Limited
22.08
-17.55
-44.28%
IN:DALMIASUG
Dalmia Bharat Sugar & Industries Ltd.
350.50
-50.11
-12.51%
IN:RANASUG
Rana Sugars Limited
14.19
-8.96
-38.70%

Insecticides (India) Limited Corporate Events

Insecticides (India) Limited Announces Q1 FY26 Earnings Conference Call
Jul 30, 2025

Insecticides (India) Limited has scheduled an earnings conference call on August 13, 2025, to discuss its Q1 and FY26 financial results. The call will feature key company executives, including the Managing Director, CFO, and Chief Marketing Officer, and will provide insights into the company’s financial performance and strategic direction.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 14, 2025